TrialmAbs

Generation of “LYmph Node Derived Antibody Libraries” (LYNDAL) for selecting fully human antibody fragments with therapeutic potential.

Philipp Diebolder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.